Bienaime Jean Jacques
Immunome, Inc. · Director
Bienaime Jean Jacques is listed in filings as Director at Immunome, Inc.. This profile follows SEC Form 4 activity through Jun 9, 2026, including purchase activity and sale activity. Recent filings connect the profile to Immunome, Inc. (IMNM), Keros Therapeutics, Inc. (KROS), Incyte Corp (INCY), and Ascendis Pharma A/S (ASND). The current snapshot covers public activity from Jun 18, 2024 to Jun 9, 2026. Reported amounts are shown as $19.3K to $116.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $22k2k shares | BuyMar 9, 2026 | $11.21 | $10.61 | |
| $12k1k shares | BuyApr 15, 2026 | $11.70 | $10.61 | |
| $11k1k shares | BuyMay 15, 2026 | $10.58 | $10.61 | |
| $98k7k shares | BuyAug 16, 2024 | $13.94 | $22.20 | |
| $57k7k shares | BuyMar 24, 2025 | $8.21 | $22.20 | |
| $61k7.8k shares | BuyMar 25, 2025 | $7.78 | $22.20 | |
| $47k5k shares | BuyJun 3, 2025 | $9.38 | $22.20 | |
| $22k1k shares | BuyMar 10, 2026 | $22.12 | $22.20 | |
| $22k1k shares | BuyMar 11, 2026 | $21.55 | $22.20 | |
| $104k5k shares | BuyMay 15, 2026 | $20.70 | $22.20 | |
| $45k200 shares | BuyMay 29, 2026 | $223.76 | $261.00 | |
| $44k200 shares | BuyMay 29, 2026 | $222.30 | $261.00 | |
| $22k100 shares | BuyMay 29, 2026 | $223.50 | $261.00 | |
| $48k200 shares | BuyMay 26, 2026 | $239.37 | $261.00 | |
| $47k200 shares | BuyMay 26, 2026 | $236.24 | $261.00 |